Sustainability Report

Overview

The report presents Aurobindo Pharma's maiden sustainability disclosure for FY21, covering worldwide manufacturing facilities and the Hyderabad corporate office. Key highlights include 5.5% reduction in carbon emissions, total energy consumption of 62,17,790 GJ, and 4.9% renewable energy used in operations. It also reports 32,317 employees, zero fatalities, and CSR activities benefiting 9,24,005 individuals, alongside 2025 goals including 12.5% carbon footprint reduction and 20% renewable energy share.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020-2021
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services